‘Diabetes is fast becoming a serious global problem. No surprise, then, that a lot of folks cheered after learning that a new drug option — the first inhaled form of insulin — will soon hit pharmacy shelves.
The drug, called Exubera, provides an option for diabetes patients who are supposed to inject themselves with insulin three to six times a day.
The discomfort and inconvenience that come with injections cause many diabetics to inject themselves fewer times than is recommended.’
- Sigma Pharmaceuticals year profit rises 27 pct
- South African citizens cheap drug guinea pigs
- Two drugs test victims face a year in coma
- Can drug companies improve their reputation?
- Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts
- Pfizer’s Forecast Disappoints
- Pharmaceutical RFID Adoption Stalls
- Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients
- GlaxoSmithKline unveils best results since merger
- Pfizer Sues Teva, Sandoz Over Zithromax